Sign In

Megan P Pereira PHARMD

Oncology Pharmacist

Phone, Open Hours, Reviews & Information

55 Park Street, New Haven, Connecticut 06511, United States
Gender: Female

 

Pharmacy Blue Star Customer Rating Customer Ratings

More practice addresses of Megan P Pereira

114 Woodland Street, Hartford, Connecticut 06105, United States

(860) 714-5242

Reviews about Megan P Pereira

No reviews. Be first - Add your review about Megan P Pereira PHARMD

Log in or sign up to post new review

Megan P Pereira has primary practice address at 55 Park Street, New Haven, Connecticut 06511, United States. Megan P Pereira works hard to the highest-quality services described below.

To make an appointment or if you have any questions please call at (860) 714-5242 for any inquiries or visit us to experience firsthand the quality services that have made us a staple in the New Haven community since they started to work on May 22 2019.

Primary focus of the Doctor / HealthCare Provider is Oncology Pharmacist. The license number is registered in State, which confirms the professionalism and compliance with healthcare standards. Source: NPPES NPI Registry

According to the official NPPES profile of the HealthCare Provider, the HealthCare Provider updated information on May 22 2019 last time, our records are a testament to our ongoing commitment to maintaining current and useful information for our customers. Pharmacy Near Me Team also tried to manually add and verify doctor appointment hours and other information with additional updates from Healthcare Insurance Companies Data. The data for this page is updated on weekly basis. Our data is cross-referenced with multiple healthcare databases(NPPES, FDA, Census, NUCC, States Divisions of Medical Quality Assurance’s Profiles Data, Health Insurance companies) to ensure the highest level of accuracy. Also, the page is reviewed quarterly by our Team to ensure accuracy.

A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.

Source: NUCC, CMS